The Cancer Cachexia Network

The sponsor of a major new clinical trial in cancer cachexia, CatalYm GmbH, is seeking your input to the trial protocol, to make sure it optimally meets the needs of people with cancer cachexia and those who care for them. We are hosting a Zoom videoconference, at which we would like to present information about the trial to up to 6 patients/caregivers living in Europe or North America. We will ask a number of questions to help us make sure that the protocol is as good as it can be for those taking part and those who may benefit from the new treatment, if it proves successful.

 

Participants will be paid an honorarium of US$100 or equivalent in any other currency for their valued participation. If you are interested involvement in this videoconference, please e-mail gabriel.fox@catalym.com. Full details of how to join the meeting will be sent to those participants.